Inventor · disambiguated record
Andrew W. Shyjan
Also filed as: SHYJAN ANDREW · SHYJAN ANDREW W
30 granted patents·13 pending applications·483 citations·filing 1995–2018
97Inventor score
Files withMILLENNIUM PHARM INC32HEINTZ NATHANIEL4MILLENIUM PHARMACEUTICALS INC1MILLINNIUM PHARMACEUTICALS INC1SHYJAN ANDREW W1
Top patents by PatentIndex Score
43 records- 0194US5674739AHuman gene FOHY030 coding for tumor progression inhibitorMILLENNIUM PHARM INC·Filed 1996·Granted Oct 7, 1997·56 cites·18 claims
- 0292US6312909B1Compositions and methods for the diagnosis prevention and treatment of tumor progressionMILLENNIUM PHARM INC·Filed 2000·Granted Nov 6, 2001·43 cites·46 claims
- 0392US5633161AMurine gene fomy030 coding for tumor progression inhibitorMILLENNIUM PHARM INC·Filed 1995·Granted May 27, 1997·45 cites·12 claims
- 0484US6506607B1Methods and compositions for the identification and assessment of prostate cancer therapies and the diagnosis of prostate cancerMILLENNIUM PHARM INC·Filed 1998·Granted Jan 14, 2003·77 cites·4 claims
- 0583US7785812B2Multidrug resistance-associated polypeptideMILLENNIUM PHARM INC·Filed 2005·Granted Aug 31, 2010·2 cites·47 claims
- 0682US6162616AMultidrug resistance-associated polypeptideMILLENNIUM PHARM INC·Filed 1997·Granted Dec 19, 2000·23 cites·28 claims
- 0782US6025137ACompositions and methods for the diagnosis, prevention and treatment of tumor progressionMILLENNIUM PHARM INC·Filed 1997·Granted Feb 15, 2000·43 cites·15 claims
- 0881US6890713B1Multidrug resistance-associated polypeptideMILLENNIUM PHARM INC·Filed 2000·Granted May 10, 2005·3 cites·24 claims
- 0979US8513485B2Non human transgenic mammal comprising a transgene comprising a nucleotide sequence encoding a ribosomal protein fused to a peptide tagHEINTZ NATHANIEL·Filed 2011·Granted Aug 20, 2013·2 cites·75 claims
- 1078US7985553B2Method for isolating cell type-specific mRNAsHEINTZ NATHANIEL·Filed 2002·Granted Jul 26, 2011·5 cites·45 claims
- 1177US6251597B1Methods for detecting fohy030MILLENNIUM PHARM INC·Filed 1998·Granted Jun 26, 2001·33 cites·35 claims
- 1273US6872811B1HRPCa9 and HRPCa10 nucleic acids and polypeptidesMILLENNIUM PHARM INC·Filed 1998·Granted Mar 29, 2005·21 cites·10 claims
- 1368US5837837ANucleic acids molecules encoding Caspase-8h and Caspase-8iMILLENNIUM PHARM INC·Filed 1997·Granted Nov 17, 1998·19 cites·18 claims
- 1468US2013030039A1Novel multidrug resistance-associated polypeptideMILLENNIUM PHARM INC·Filed 2012·Application pending·0 cites
- 1566US2005106600A1Compositions and methods for the diagnosis, prevention and treatment of tumor progressionMILLINNIUM PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1664US2019119670A1Method for isolating cell-type specific mrnasHEINTZ NATHANIEL·Filed 2018·Application pending·0 cites
- 1762US5994130AMultidrug resistance-associated polypeptideMILLENNIUM PHARM INC·Filed 1997·Granted Nov 30, 1999·11 cites·10 claims
- 1861US2014196176A1Method for Isolating Cell-Type Specific mRNAsHEINTZ NATHANIEL·Filed 2013·Application pending·0 cites
- 1961US2004091948A1Chk1 and uses thereofMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 2058US6723498B1Chk1 and uses thereofMILLENNIUM PHARM INC·Filed 1999·Granted Apr 20, 2004·18 cites·38 claims
- 2158US6172190B1Caspase-8h and Caspase-8i-polypeptidesMILLENNIUM PHARM INC·Filed 1997·Granted Jan 9, 2001·15 cites·6 claims
- 2258US6100031AMethods for diagnosis of colon cancer by detecting Roch083 mRNAMILLENNIUM PHARM INC·Filed 1998·Granted Aug 8, 2000·14 cites·7 claims
- 2356US2003119740A1Compositions and methods for the diagnosis, prevention and treatment of tumor progressionMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2453US8287862B2Multidrug resistance-associated polypeptideSHYJAN ANDREW W·Filed 2010·Granted Oct 16, 2012·0 cites·25 claims
- 2553US2003138865A1Nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancerMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2652US6077936AMultidrug resistance-associated polypeptideMILLENNIUM PHARM INC·Filed 1998·Granted Jun 20, 2000·3 cites·9 claims
- 2750US5932422AModulation of drug resistance via ubiquitin carboxy-terminal hydrolaseMILLENNIUM PHARM INC·Filed 1997·Granted Aug 3, 1999·10 cites·27 claims
- 2848US6458939B1Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferationMILLENNIUM PHARM INC·Filed 1997·Granted Oct 1, 2002·3 cites·27 claims
- 2947US6423494B1DR6 and uses thereofMILLENNIUM PHARM INC·Filed 1999·Granted Jul 23, 2002·15 cites·15 claims
- 3046US6316204B1Methods for detecting fohy030 polypeptideMILLENNIUM PHARM INC·Filed 1999·Granted Nov 13, 2001·4 cites·21 claims
- 3145US2003129629A1Methods and compositions for the identification, assessment, prevention, and therapy of human cancersMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 3243US6268470B1Composition and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferationMILLENNIUM PHARM INC·Filed 1997·Granted Jul 31, 2001·4 cites·3 claims
- 3342US6355430B1Diagnostic and screening methods employing KIAA0101MILLENNIUM PHARM INC·Filed 1999·Granted Mar 12, 2002·8 cites·14 claims
- 3442US2005100931A1Methods and compositions for the identification and assessment of prostate cancer therapies and the diagnosis of prostate cancerMILLENNIUM PHARM INC·Filed 2004·Application pending·0 cites
- 3542US2003175704A1Genes expressed in lung cancerFiled 2001·Application pending·0 cites
- 3641US2002120004A1Methods and compositions for the identification, assessment, prevention and therapy of human cancersFiled 2001·Application pending·0 cites
- 3739US6825320B1FOHY03 polypeptidesMILLENIUM PHARMACEUTICALS INC·Filed 1997·Granted Nov 30, 2004·2 cites·16 claims
- 3837US2002051978A1Methods and compositions for the identification, assessment, prevention and therapy of human cancersFiled 2001·Application pending·0 cites
- 3932US6794185B1fohy030 nucleic acid moleculesMILLENNIUM PHARM INC·Filed 1998·Granted Sep 21, 2004·0 cites·12 claims
- 4032US6372896B1Kits for detecting fOHY030MILLENNIUM PHARM INC·Filed 1998·Granted Apr 16, 2002·1 cites·64 claims
- 4131US6322982B1Modulation of drug resistance via ubiquitin carboxy-terminal hydrolaseMILLENNIUM PHARM INC·Filed 1999·Granted Nov 27, 2001·0 cites·16 claims
- 4230US6485921B1UBCLP and uses thereofMILLENNIUM PHARM INC·Filed 1998·Granted Nov 26, 2002·3 cites·14 claims
- 4321US2002006613A1Methods and compositions for the identification and assessment of cancer therapiesFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew W. Shyjan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →